Dose-Response: A Fundamental Concept in Toxicology

Sixth Edition: Hayes’ Principles and Methods of Toxicology

Volumn , Issue , 2014, Pages 89-140

  Calabrese, Edward J ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85078441119     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b17359-13     Document Type: Chapter

References (328)

1. National Research Council (NRC). Science and Decisions: Advancing Risk Assessment. Committee on Improving Risk Analysis Approaches used by EPA. December 2, 2008; 36 p.
2. Environmental Protection Agency (EPA). An examination of EPA risk assessment principles and practices. Prepared by members of the Risk Assessment Task Force (EPA/100/B/001) March, Washington, DC, 2004.
3. Calabrese EJ, Baldwin LA. Chemical hormesis: Its historical foundations as a biological hypothesis. Hum Exp Toxicol 2000; 19(1):2-31.
4. Calabrese EJ, Baldwin LA. The marginalization of hormesis. Hum Exp Toxicol 2000; 19(1):32-40.
5. Calabrese EJ, Baldwin LA. Radiation hormesis: Its historical foundations as a biological hypothesis. Hum Exp Toxicol 2000; 19:41-75.
6. Calabrese EJ, Baldwin LA. Radiation hormesis: Part 2-The demise of a legitimate hypothesis. Hum Exp Toxicol 2000; 19:76-84.
7. Calabrese EJ, Baldwin LA. Tales of two similar hypotheses: The rise and fall of chemical and radiation hormesis. Hum Exp Toxicol 2000; 19:86-97.
8. Calabrese EJ. Getting the dose-response wrong. Why hormesis marginalized and the threshold model accepted. Arch Toxicol 2009; 83:227-247.
9. Calabrese EJ. The road to linearity: Why linearity at low doses became the basis for carcinogen risk assessment. Arch Toxicol 2009; 83:203-225.
10. Calabrese EJ. Muller’s Nobel Prize lecture: When ideology prevailed over science. Toxicol Sci 2012; 126(1):1-4.
11. Calabrese EJ. Hormesis and the Salk vaccine. Dose Response 2012; 10(1):91-95.
12. Fisher RA. The correlation between relatives on the supposition of Mendelian inheritance. Philos Trans R Soc Edinburgh 1918; 52:399-433.
13. Koch R. Ueber Desinfection. Mitlheil a. d. Kaiserl. Gesundheitsamte Vol (1). (Cited in Chick and Martin, 1908) 1881.
14. Chick H. An investigation of the laws of disinfection. J Hyg 1908; 8(1):92-158.
15. Chick H, Martin CJ. The principles involved in the standardization of disinfectants and the influence of organic matter upon germicidal value. J Hyg 1908; 8(5):654-697.
16. Lee ER, Gilbert CA. On the application of the mass law to the process of disinfection-Being a contribution to the “mechanistic theory” as opposed to the “vitalistic theory”. J Phys Chem 1918; 22(5):348-372.
17. Eaton DL. Scientific judgment and toxic torts-A primer in toxicology for judges and lawyers. 12 J.L. and POL’Y 5, 2003; 15.
18. Coulter HL. Homoeopathic Medicine. Washington, DC: American Foundation of Homoeopathy, 1972; 73pp.
19. Perrin J. Brownian Movement and Molecular Reality (trans. F Soddy). London, U.K.: Taylor and Francis Group. (This is a translation of a paper that appeared in the Annales de Chimie et de Physique, 8me Series, 1909). 1910; 93pp.
20. Wolf P. Eighteen Theses. Illustrating the principles of homeopathy, according to their true sense and scientific acceptation, addressed to the friends and opponents of that method of cure (translated from the German, by CF Matlack, MD). In: Association of Homoeopathic Physicians (ed.) Miscellanies on Homoeopathy. Philadelphia, PA: WLJ Kiderlen and Co., 1839.
21. Coulter HL. Divided Legacy: The Conflict between Homoeopathy and the American Medical Association. Berkeley, CA: North Atlantic Books, 1982; 552pp.
22. Bernard C. Lecons sur le Diabete et la Glycogenese Animale. France, Paris: Librarie J. B. Bailliere et Fils, 1877; 132pp.
23. Schulz H. Zur Lehre von der Arzneiwirdung. Virchows Archiv Pathol Anatom Physiol Klin Med 1887; 108:423-445.
24. Schulz H. Uber Hefegifte. Pflugers Archiv Physiol Menschen Tiere 1888; 42:517-541.
25. Bohme H. 1986. Hugo Schulz (8/6/1853-7/13/1932). His life and work. Dissertation. Freien University of Berlin, Berlin, Germany, 1986.
26. Crump T. NIH Library Translation (NIH-98-134). Contemporary medicine as presented by its practitioners themselves, Leipzig, 1923:217-250, Hugo Schulz. Nonlinearity Biol Toxicol Med 2003; 1:295-318.
27. Bloedau CV. General Medical Central 1884; 93:1362 (Cited in Schulz, 1885).
28. Schulz H. About the treatment of cholera with veratrine. German Med Weekly Pap 1885; 11:99.
29. Calabrese EJ. Toxicology rewrites its history and rethinks its future: Giving equal focus to both harmful and beneficial effects. Environ Toxicol Chem 2011; 30(12):2658-2673.
30. Kotschau K. The effect of small doses with reference to the Arndt-Schulz law and homeopathy, Part 2. Deut Med Wochenschrift 1928; 54:1586-1588.
31. Kotschau K. The effect of small doses with reference to the Arndt-Schulz law and the homeopathy, Part 2. Deut Med Wochenschrift 1928; 54:1631-1632.
32. Schulz H. 1918. Rudolf Arndt and the Fundamental Law of Biology. Greifswald, L. Bamberg, Germany.
33. Wels P. The life time work of Hugo Schulz. Naunyn-Schmiedebergs Archiv Exper Pathol Pharmakol 1933; 170:744-757.
34. Martius-Rostock F. The Arndt-Schulz axiom. The Munich Med Weekly News 1923; 70(31):1-4.
35. Clark AJ. Mode of Action of Drugs on Cells. London, U.K.: Arnold, 1933; 298pp.
36. Clark AJ. Handbook of Experimental Pharmacology. Berlin, Germany: Verlig Von Julius Springer, 1937.
37. Dannenberg H. Yeast fermentation: On the question of the validity of the Arndt-Schulz rule. Naunyn-Schmiedebergs Arch Exper Pathol Pharmakol 1930; 154:211-221.
38. Branham SE. The effects of certain chemical compounds upon the course of gas production by Baker’s yeast. J Bacteriol 1929; 18:247-284.
39. Calabrese EJ. Key studies to support cancer risk assessment questioned. Environ Mol Mutagen 2011; 52(8):595-606.
40. Calabrese EJ. Muller’s Nobel lecture on dose-response for ionizing radiation: Ideology or science? Arch Toxicol 2011; 85(12):1495-1498.
41. Duggar BM. Aureomycin: A product of the continuing search for new antibiotics. Ann N Y Acad Sci 1948; 51:177-181.
42. Rahn O. The rate of fermentation (Chapter 5). In: Physiology of Bacteria. Philadelphia, PA: P. Blakiston’s Son and Co., Inc., 1932; pp. 137-140.
43. Hofmann P. Ueber die Gültigkeit des Arndt-Schulz’schen Grundgesetzes bei der Wirkung von Bakteriengiften. Dissertation, tierärztl. Fakultät, München, Germany, 1922.
44. Townsend CO. The correlation of growth under the influence of injuries. Ann Botany 1897; 11:509-532.
45. Hueppe F. Principles of Bacteriology (translated from the German by E.O. Jordan). Chicago, IL: The Open Court Publishing Company, 1896; 457pp.
46. Calabrese EJ, Dhawan G. The role of x-rays in the treatment of gas gangrene: A historical assessment. Dose-Response 2012; 10(4):626-643. DOI:10.2203/dose-response.12-016.Calabrese.
47. Calabrese EJ, Calabrese V. 2013. Reduction of arthritic symptoms by low dose radiation therapy (LD-RT) is associated with an anti-inflammatory phenotype. Int J Radiat Biol 2012; 89(4):278-286.
48. Duggar BM. Plant Physiology, with Special Reference to Plant Production. New York: Macmillan, 1911; 516pp.
49. Salle AJ. 1939. Fundamental Principles of Bacteriology. New York: McGraw-Hill Book Company, 1939; pp. 166-197.
50. Clifton CE. Introduction to Bacterial Physiology. New York: McGraw-Hill, 1957; pp. 317-338.
51. Lamanna C, Mallette MF. Basic Bacteriology: Its Biological and Chemical Background, 3rd edn. Baltimore, MD: Lippincott Williams and Wilkins Company, 1965; 1001pp.
52. Marshall MS, Hrenoff AK. Bacteriostasis. J Infect Dis 1937; 61:42-54.
53. Luckey TD. Ionizing Radiation and Hormesis. Boca Raton, FL: CRC Press, 1980.
54. Luckey TD. Radiation Hormesis. Boca Raton, FL: CRC Press, 1991; 306pp.
55. Richards HM. The effect of chemical irritation on the economic coefficient of sugar. Bull Torrey Bot Club 1899; 26:463-479.
56. Richards HM. On the nature of response to chemical stimulation. Science 1910; 31:52-62.
57. Falk IS. The role of certain ions in bacterial physiology. A review (Studies of Salt Action, VIII). Abstr Bacteriol 1923; 7:33-50, 87-105, 133-147.
58. Hotchkiss M. The influence of various salts upon the growth of bacterium communis. PhD thesis. Yale University, New Haven, CT, 1922.
59. Hotchkiss M. Studies on Salt Action: VI. The stimulating and inhibitive effect of certain cations upon bacterial growth. J Bacteriol 1923; 8:141-162.
60. Shackell LF. The relation of dosage to effect. II. J Pharmacol Exp Ther 1925; 15:275-288.
61. Shackell LF, Williamson W, Deitchmann MM et al. The relation of dosage to effect. J Pharmacol Exp Ther 1924/1925; 23/24:53-65.
62. Cushny AR. The Secretion of the Urine. London, U.K.: Longmans, Green and Company, 1926; 288pp.
63. Foster RHK. Standardization of safety margin. J Pharmacol Exp Ther 1939; 65(1):1-17.
64. Taylor LS. Radiation Protection Standards. CRC Monotopics Series. Cleveland, OH: Chemical Rubber Company Press, 1971; 110pp.
65. Lehman AJ, Fitzhugh OG. 100-Fold margin of safety. Assoc Food Drug Off, Quart Bull 1953; 17(2):33-35.
66. Flexner A. Medical education in the United States and Canada. A Report to the Carnegie Foundation for the Advancement of Teaching, New York, 1910; 887pp.
67. Berliner H. A System of Scientific Medicine. New York: Tauistock Publication, 1985; 190pp.
68. Clark AJ. The reaction between acetyl choline and muscle cells. J Physiol 1926; 61:530-546.
69. Clark AJ. The historical aspects of quackery, Part 2. Brit Med J 1927; 589-590, 756, 748, and 960.
70. Clark AJ. Applied Pharmacology. Philadelphia, PA: P. Blakiston’s Son and Co., 1927; 678pp.
71. Bliss CI. The comparison of dosage-mortality data. Ann Appl Biol 1935; 22:307-333.
72. Bliss CI. Estimating the dosage-mortality curve. J Econ Entomol 1935; 25:646-647.
73. Bliss CI. The calculation of the dosage-mortality curve. Ann Appl Biol 1935; 22:134-167.
74. Bliss CI. The toxicity of poisons applied jointly. Ann Appl Biol 1939; 26:585-615.
75. Bliss CI. Biometry in the service of biological assay. Ind Eng Chem 1941; 13:84-88.
76. Bliss CI. The calculation of microbial assays. Bacteriol Rev 1956; 20:243-258.
77. Bliss CI. Some principles of bioassay. Am Sci 1957; 45:449-466.
78. Bliss CI, Packard C. Stability of the standard dosage-effect curve for radiation. Am J Roentgenol Rad Ther 1941; 46:400-404.
79. Bliss CI, McKeen C. Biological assay. Ann Rev Physiol 1943; 5:479-539.
80. Gaddum JH. Methods of Biological Assay Depending on the Quantal Response. London, U.K.: H.M. Stationery Office, 1933; 46pp.
81. Southam CM, Ehrlich J. Effects of extracts of western redcedar heartwood on certain wood-decaying fungi in culture. Phytopathology 1943; 33:517-524.
82. Whittemore FG Jr. The National Committee on Radiation Protection, 1928-1960: From professional guidelines to government regulation. Thesis. Department of History of Science, Harvard University, Cambridge, MA, 1986.
83. Jolly C. Thresholds of uncertainty: Radiation and responsibility in the fallout controversy. PhD dissertation. Oregon State University, Corvallis, OR, 2003; 591pp.
84. Mutscheller A. Physical standards of protection against roentgen ray dangers. Am J Roentgenol Radiat Ther 1925; 13:65-70.
85. Mutscheller A. Safety standards of protection against x-ray danger. Radiology 1928; 10:468-476.
86. Sievert R. Einige untersuchungen uber vorricht ungen zum schutz gegen roentgenstrahlen. Acta Radiol 1925; 4:61.
87. Barclay AE, Cox S. Radiation risks of the roentgenologist. Am J Roentgenol Radiat Ther 1928; 19:551-561.
88. Muller HJ. Artificial transmutation of the gene. Science 1927; 66:84-87.
89. Muller HJ. The problem of genetic modification. Verhandlungen des V. Internationalen Kongresses fur Vererbungswissenschaft (Berlin, 1927) in Zeitschrift fur inductive abstammungs- und Vererbungslehre. Suppl Band 1928; 1:234-260.
90. Stadler LJ. Some genetic effect of x-rays in plants. J Hered 1930; 21:3-19.
91. Hutchinson GE. The biogeochemistry of aluminum and of certain related elements (concluded). Quart Rev Biol 1943; 18(4):331-363.
92. Hutchinson GE. The influence of the environment. Proc Natl Acad Sci USA 1964; 51(5):930-934.
93. Dinman DB. Non-concept of no threshold-Chemicals in environment. Science 1972; 4021:495-497.
94. Webb JL. Enzyme and Metabolic Inhibitors, Vol. 3. New York: Academic Press, 1966; 1028pp.
95. Cornfield J, Rai K, Van Ryzin J. Procedures for assessing risk at low levels of exposure. Arch Toxicol 1980; 3:295-303.
96. Schaeffer D. Thresholds for carcinogenesis and their significance to medical practice. Med Hypotheses 1983; 10:175-184.
97. Pollycove M, Feinendegen LE. Radiation-induced versus endogenous DNA damage: Possible effect of inducible protective responses in mitigating endogenous damage. Hum Exp Toxicol 2003; 22(6):290-306.
98. Green DE, Vande Zande HD. Universal energy principle of biological systems and the unity of bioenergetics. Proc Natl Acad Sci USA 1981; 78(9):5344-5347.
99. Schaeffer DJ, Janardan KG, Kerster HW. Threshold estimation from the linear dose-response model: Method and radiation data. Environ Manage 1981; 5(6):515-520.
100. Schaeffer DJ, Kerster HW, Janardan KG. The low dose extrapolation problem: A review and a new model. Am J Math Manage Sci 1982; 2(3):223-251.
101. Janardan KG, Kerster HW, Schaeffer DJ. Biological applications of the Lagrangian poisson distribution. BioScience 1979; 29(10):599-602.
102. Schaeffer DJ, Janardan KG, Kerster HW, Clarke ACM. Statistically estimated free energies of chromosome aberration production from frequency data. Biometrical J 1983; 25(3):275-282.
103. Koch R. A threshold concept of environmental Pollutants. Chemosphere 1983; 12(1):17-21.
104. Friedman L. Problems of evaluating the health significance of the chemicals present in foods. In: Pharmacology and the Future of Man (Proceedings of the Fifth International Congress on Pharmacology), (GH Acheson, Editor) Vol. 2. Karger: Basel, Switzerland, 1973; pp. 30-41.
105. Claus G. Environmental carcinogens: Is there a threshold of exposure? Clin Toxicol 1974; 7(5):497-508.
106. Jukes TH. A quantitative evaluation of estrogens, including DES, in the diet. Am Stat 1982; 36(3):273-277.
107. Preussmann R. The problem of thresholds in chemical carcinogenesis, some views on theoretical and practical aspects. J Cancer Res Clin Oncol 1980; 97:1-14.
108. Mohr U, Hilfrich H. Effect of a single dose of N-diethylnitrosamine on the rat kidney. J Natl Cancer Inst 1972; 49:1729-1731.
109. Williams GM, Iatropoulos MJ, Jeffrey AM. Mechanistic basis for nonlinearities and thresholds in rat liver carcinogenesis by the DNA-reactive carcinogens 2-acetylaminofluorene and diethylnitrosamine. Toxicol Pathol 2000; 28(3):388-395.
110. Williams GM, Iatropoulos MJ, Jeffrey AM. Thresholds for the effects of 2-acetylaminofluorene in rat liver. Toxicol Pathol 2004; 32:85-91.
111. Williams GM, Iatropoulos MJ, Jeffrey AM. Thresholds for DNA-reactive (genotoxic) organic carcinogens. Toxicol Pathol 2005; 18:69-77.
112. Parry JM, Jenkins GJS, Haddad F et al. In vitro and in vivo extrapolations of genotoxin exposures: Consideration of factors which influence dose-response thresholds. Mutat Res 2000; 464:53-63.
113. Claus G, Bolander K, Krisko I. Man-made chemical mutagens in the natural environment: An evaluation of hazards. Studia Biophys (Berlin) 1975; 50:123-136.
114. Fahmy OG, Fahmy MJ. The genetic effects of the biological alkylating agents with reference to pesticides. Ann N Y Acad Sci 1969; 160(1):228-243.
115. Ames BN. The detection of chemical mutagens with enteric bacteria. In: Chemical Mutagens: Principles and Methods for Their Detection. (A Hollaender, Editor) New York: Plenum Press, 1971; pp. 267-282.
116. Slikker Jr W, Andersen ME, Bogdanffy MS et al. Dosedependent transition in mechanisms of toxicity. Toxicol Appl Pharmacol 2004; 201:203-225.
117. Slikker Jr W, Andersen ME, Bogdanffy MS et al. Dosedependent transitions in mechanisms of toxicity: Case studies. Toxicol Appl Pharmacol 2004; 201:226-294.
118. Monticello TM, Swenberg JA, Gross EA et al. Correlation of regional and nonlinear formaldehyde-induced nasal cancer with proliferating populations of cells. Cancer Res 1996; 56:1012-1022.
119. Belinsky SA, Walker VE, Maronpot RR et al. Molecular dosimetry of DNA adduct formation and cell toxicity in rat nasal-mucosa following exposure to the tobacco specific nitrosamine 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone and their relationship to induction of neoplasia. Cancer Res 1987; 47(22):6058-6065.
120. Rozman KK, Kerecsen L, Viluksela MK et al. A toxicologist’s view of cancer risk assessment. Drug Metab Rev 1996; 28(1 and 2):29-52.
121. Gaddum JH. Lognormal distributions. Nature 1945; 156:463.
122. Tritscher AM, Goldstein JA, Portier CJ et al. Dose-response relationships for chronic exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: Quantification and immunolocalization of CYP 1A1 and CYP 1A2 in the liver. Cancer Res 1992; 52:3436-3442.
123. Waddell WJ, Crooks NH, Carmichael PL. Correlation of tumors with DNA adducts from methyl eugenol and tamoxifen in rats. Toxicol Sci 2004; 79:38-40.
124. Waddell WJ. Threshold of carcinogenicity of flavors. Toxicol Sci 2002; 68:275-279.
125. Waddell WJ. Thresholds in chemical carcinogenesis: What are animal experiments telling us? Toxicol Pathol 2003; 31(3):260-262.
126. Waddell WJ. Threshold for carcinogenicity of N-nitrosodiethylamine for esophageal tumors in rats. Food Chem Toxicol 2003; 41:739-741.
127. Waddell WJ. Threshold of carcinogenicity in the ED01 study. Toxicol Sci 2003; 72:158-163.
128. Waddell WJ. Rebuttal to Haseman. Toxicol Pathol 2003; 31:712-713.
129. Waddell WJ. Letters to the editor-Reply. Toxicol Sci 2003; 74:485-486.
130. Waddell WJ. Letters to the editor-Reply. Toxicol Sci 2003; 74:487-488.
131. Waddell WJ. Analysis of thresholds for carcinogenicity. Toxicol Lett 2004; 149:415-419.
132. Waddell WJ. Comparisons of thresholds for carcinogenicity on linear and logarithmic dosage scales. Hum Exp Toxicol 2005; 24:325-332.
133. Waddell WJ. Critique of dose response in carcinogenesis. Hum Exp Toxicol 2006; 25(7):413-436.
134. Waddell WJ. History of dose response. J Toxicol Sci 2010; 35(1):1-8.
135. Crump KS, Clewell HJ. Letters to the Editor. Toxicol Sci 2003; 74:485-488.
136. Andersen ME, Conolly RB, Gaylor DW. Letters to the editor-Letter. Toxicol Sci 2003; 74:486-487.
137. Lutz WK. Letters to the editor. Toxicol Sci 2003; 75:223-225.
138. Haseman JJK. Response to Waddell and Rozman. Toxicol Pathol 2003; 31(6):715-716.
139. Enomoto M. Thresholds in chemical carcinogenesis: What are animal experiments telling us? Toxicol Pathol 2003; 31:573-574.
140. Rozman KK. Rebuttal to Haseman. Toxicol Pathol 2003; 31:714.
141. National Academy of Sciences (NAS)/National Research Council (NRC). The biological effects of atomic radiation: A report to the public. Washington, DC: NAS/NRC, 1956.
142. Lewis EB. Leukemia and ionizing radiation. Science 1957; 125:965-972.
143. DuShane G. Loaded dice. Science 1957; 125:964.
144. Caspari E, Stern C. The influence of chronic irradiation with gamma-rays at low dosages on the mutation rate in Drosophila melanogaster. Genetics 1948; 33:75-95.
145. Muller HJ. The production of mutations. Nobel Lecture, 1946. Nobleprize.org (http:www.nobelprize.org/nobel-prizes/medicine/laureates/1946).
146. Crow JF. Quarreling geneticists and a diplomat. Genetics 1995; 140:421-426.
147. Henry HF. Is all nuclear radiation harmful? J Am Med Assoc 1961; 176(8):671-675.
148. Henahan JF. Whatever happened to the Cranberry Crisis. The Atlantic Monthly 1977; 239:26-36.
149. National Academy of Sciences (NAS)/National Research Council (NRC). The Effects on Populations of Exposure to Low Levels of Ionizing Radiation. Washington, DC: Division of Medical Sciences, 1972.
150. National Academy of Sciences Safe Drinking Water Committee (NAS SDWC). Drinking Water and Health. Washington, DC: National Academy of Sciences, 1977.
151. Fisher JC, Hollomon JH. A hypothesis for the origin of cancer foci. Cancer 1951; 4(5):916-918.
152. Muller HJ. Radiation damage to the genetic material. Sci Prog 1951; 7:93-94.
153. Iversen S, Arley N. On the mechanism of experimental carcinogenesis. Acta Pathol Microbiol Scand 1950; 27:773-803.
154. Nordling CO. A new theory on the cancer-inducing mechanism. Br J Cancer 1953; 7:68-72.
155. Driver HE, White INH, Butler WH. Dose-response relationships in chemical carcinogenesis-Renal mesenchymal tumors induced in the rat by single dose dimethylnitrosamine. Br J Exp Pathol 1987; 68(2):133-143.
156. Ogura K, Magae J, Kawakami Y, Koana T. Reduction in mutation frequency by very low-dose gamma irradiation of Drosophila melanogaster germ cells. Radiat Res 2009; 171(1):1-8.
157. Luckey TD, Venugopal B, Hutcheson D. Heavy Metal Toxicity Safety and Hormology. New York: Academic Press, 1975; 120pp.
158. Elliott KC. Is A Little Pollution Good For You? Incorporating Societal Values into Environmental Research. London, U.K.: Oxford University Press, 2011; 246pp.
159. Thayer KA, Melnick R, Burns K et al. 2005. Fundamental flaws of hormesis for public health decisions. Environ Health Perspect 2005; 113:1271-1276.
160. Thayer KA, Melnick R, Huff J et al. Hormesis: A new religion? Environ Health Perspect 2006; 114:A632-A633.
161. Axelrod D, Burns K, Davis D et al. Hormesis-An inappropriate extrapolation from the specific to the universal. Int J Occup Environ Health 2004; 10:335-339.
162. Sagan LA. On radiation, paradigms, and hormesis. Science 1989; 245:574-621.
163. Wolff S. Are radiation-induced effects hormetic. Science 1989; 245:575-621.
164. Szabadi E. A theoretical model of two functionally opposite receptor populations. Br J Pharmacol 55(2):311
165. Proceedings of the B. P. S. (September 15-17, 1975) Edinburgh, Scotland, 1975; 311pp.
166. Szabadi E. Model of 2 functionally antagonistic receptor populations activated by same agonist. J Theor Biol 1977; 69:101-112.
167. Dale HH. On some physiological actions of ergot. J Physiol (London) 1906; 34(3):163-206.
168. Alfonzo MJ, de Becemberg IL, de Villaroel SS et al. Two opposite signal transducing mechanisms regulate a G-proteincoupled guanylyl cyclase. Arch Biochem Biophys 1998; 350(1):19-25.
169. Rovati GE, Nicosia S. Lower efficacy-Interaction with an inhibitory receptor or partial agonism. Trends Pharmacol Sci 1994; 15(5):140-144.
170. Rovati GE, Nicosia S. An alternative model for bell-shaped concentration-response curves-Reply. Trends Pharmacol Sci 1994; 15(9):321-322.
171. Jarv J. A model of nonexclusive binding of agonist and antagonist on G-protein coupled receptors. J Theor Biol 1995; 175(4):577-582.
172. Accomazzo MR, Cattaneo S, Nicosia S et al. Bell-shaped curves for prostaglandin-induced modulation of adenylate cyclase: Two mutually opposing effects. Eur J Pharmacol 2002; 454:107-114.
173. Marmot MG, Rose G, Shipley MJ et al. Alcohol and mortality-A U-shaped curve. Lancet 1981; 1:580-583.
174. Stebbing ARD. Hormesis-The stimulation of growth by lowlevels of inhibitors. Sci Total Environ 1982; 22(3):213-234.
175. Stebbing ARD. A theory for growth hormesis. Mutat Res 1998; 403(1-2):249-258.
176. Stebbing A. A Cybernetic View of Biological Growth: The Maia Hypothesis. New York: Cambridge University Press, 2011; 436pp.
177. Samson L, Cairns J. A new pathway for DNA in Escherichia coli. Nature 1977; 267:281-283.
178. Olivieri G, Bodycote J, Wolff S. Adaptive response of humanlymphocytes to low concentrations of radioactive thymidine. Science 1984; 223(4636):594-597.
179. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia-A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74:1124-1136.
180. Calabrese EJ, Blain R. The occurrence of hormetic dose response in the toxicological literature, the hormesis database: An overview. Toxicol Appl Pharmacol 2005; 202(3):289-301.
181. Calabrese EJ, Blain RB. Hormesis and plant biology. Environ Pollut 2009; 157(1):42-48.
182. Calabrese EJ, Blain RB. The hormesis database: The occurrence of hormetic dose responses in the toxicological literature. Regul Toxicol Pharmacol 2011; 61(1):73-81.
183. Calabrese EJ, Baldwin LA. Defining hormesis. Hum Exp Toxicol 2002; 21(2):91-97.
184. Calabrese EJ. Converging concepts: Adaptive response, preconditioning, and the Yerkes-Dodson Law are manifestations of hormesis. Ageing Res Rev 2008; 7(1):8-20.
185. Calabrese EJ. Hormesis: Why it is important to toxicology and toxicologists. Environ Toxicol Chem 2008; 27(7):1451-1474.
186. Mattson MP. Hormesis defined. Ageing Res Rev 2008; 7(1):1-7.
187. Calabrese EJ, Baldwin LA. The frequency of U-shaped dose responses in the toxicological literature. Toxicol Sci 2001; 62(2):330-338.
188. Calabrese EJ, Baldwin LA. Hormesis: U-shaped dose responses and their centrality in toxicology. Trends Pharmacol Sci 2001; 22(6):285-291.
189. Calabrese EJ, Baldwin LA. U-shaped dose responses in biology, toxicology, and public health. Annu Rev Public Health 2001; 22:15-22.
190. Calabrese EJ, Baldwin LA. The hormetic dose-response model is more common than the threshold model in toxicology. Toxicol Sci 2003; 71(2):246-250.
191. Calabrese EJ, Baldwin LA. Chemotherapeutics and hormesis. Crit Rev Toxicol 2003; 33:305-353.
192. Calabrese EJ, Staudenmayer JW, Stanek III EJ et al. Hormesis outperforms threshold model in National Cancer Institute antitumor drug screening database. Toxicol Sci 2006; 94(2):368-378.
193. Calabrese EJ, Stanek III EJ, Nascarella MA et al. Hormesis predicts low-dose responses better than threshold models. Int J Toxicol 2008; 27(5):369-378.
194. Calabrese EJ, Hoffmann GR, Stanek EJ et al. Hormesis in high-throughput screening of antibacterial compounds in E. coli. Hum Exp Toxicol 2010; 29(8):667-677.
195. Gaylor DW. The ED01 study: Summary and conclusions. J Environ Pathol Toxicol 1980; 3:179-183.
196. Cairns T. ED01 study: Introduction, objectives and experimental design. J Environ Pathol Toxicol 1980; 3:1-7.
197. Staffa JA, Mehlman MA. Innovations in cancer risk assessment (ED01 study). J Environ Pathol Toxicol (Special Issue) 1980; 3:1-246.
198. Bruce RD, Carlton WW, Ferber KH et al. (Members of the Society of Toxicology ED01 Task Force). Re-examination of the ED01 study-Adjusting for time on study. Fundam Appl Toxicol 1981; 1:67-80.
199. Calabrese EJ. Evidence that hormesis represents an “overcompensation”response to a disruption in homeostasis. Ecotoxicol Environ Saf 1999; 42:135-137.
200. Calabrese EJ. Overcompensation stimulation: A mechanism for hormetic effects. Crit Rev Toxicol 2001; 31(4-5):425-470.
201. Hilbert DW, Swift DM, Detling JK et al. Relative growth rates and the grazing optimization hypothesis. Oecologia (Berlin), 1981; 51:14-18.
202. Calabrese EJ, Mattson MP. Hormesis provides a generalized quantitative estimate of biological plasticity. J Cell Commun Signal 2011; 5:25-38.
203. Begley S. Train Your Mind, Change Your Brain. New York: Balantine Books, 2007; 304pp.
204. Bradshaw AD. Evolutionary significance of phenotypic plasticity in plants. Adv Genet 1965; 13:115-155.
205. Carrel A. Artificial activation of the growth in vitro of connective tissue. J Exp Med 1913; 17:14-19.
206. Calabrese EJ. Historical foundations of wound healing and its potential for acceleration: Dose-response considerations. Wound Rep Reg 2013; 21(2):180-193.
207. Gaddum JH. The pharmacologist of Edinburgh. Annu Rev 1962; 2:1-10.
208. Calabrese EJ. Hormesis and pharmacology. In: Hacker M, Bachmann K, Messer W (eds.). Pharmacology Principles and Practice. Burlington, MA: Academic Press, 2009; pp. 75-102.
209. Stephenson RP. A modification of receptor theory. Br J Pharmacol 1956; 11:379-393.
210. Ariens EJ. Affinity and intrinsic. Arch Intern Pharmacodyn 1954; 99:273-278.
211. Del Castillo J, Katz B. The identity of intrinsic and extrinsic acetylcholine receptors in the motor end-plate. Proc R Soc B Biol Sci 1957; 146(924):357-361.
212. Del Castillo J, Katz B. A comparison of acetylcholine and stable depolarizing agents. Proc R Soc B Biol Sci 1957; 146(924):362-368.
213. Del Castillo J, Katz B. Interaction at end-plate receptors between different choline derivatives. Proc R Soc B Biol Sci 1957; 146(924):369-380.
214. Ariens EJ, Van Rossum JM, Simonis AM. Affinity, intrinsic activity and drug interactions. Pharmacol Rev 1957; 9:218-236.
215. Furchgott RF. The pharmacology of vascular smooth muscle. Pharmacol Rev 1955; 7(2):183-265.
216. Okpako DR. Dual action of histamine on guinea pig lung vessels. Br J Pharmacol 1972; 45(2):311-321.
217. Eyre P. Histamine H2-receptors in sheep bronchus and cat trachea-Action of burimamide. Br J Pharmacol 1973; 48(2):321-323.
218. Kehoe J. Ionic mechanisms of a 2-component cholinergic inhibition in aplysia neurons. J Physiol (London) 1972; 225(1):85-114.
219. Ascher P. Inhibitory and excitatory effects of dopamine on aplysia neurons. J Physiol 1972; 225:173-209.
220. Gerschen HM, Paupardi D. Ionic mechanisms and receptor properties underlying responses of molluscan neurons to 5-hydroxytryptamine. J Physiol (London) 1974; 243(2):427-456.
221. De Groat WC, Lalley PM. Interaction between picrotoxin and 5-hydroxytryptamine in superior cervical ganglion of cat. Br J Pharmacol 1973; 48(2):233-244.
222. Brimble MJ, Wallis DI. Histamine H1 and H2-receptors at a ganglionic synapse. Nature 1973; 246(5429):156-158.
223. Ariens EJ, Simonis AM, Van Rossum JM. Drug-receptor interaction: Interaction of one or more drugs with different receptor systems. In: Ariens EJ (ed.). Molecular Pharmacology. New York: Academic Press, 1964; pp. 287-393.
224. Jarv J. An alternative model for model-shaped concentration response curve. Trends Pharmacol Sci 1994; 15:321.
225. Leff P. Theoretical treatment of one-agonist-2-receptor systems. Trends Pharmacol Sci 1994; 15(9):320-321.
226. Barlow RB. Problems associated with the partiality of a partial agonist. Trends Pharmacol Sci 1994; 15:320.
227. Quirk SJ, Gannell JE, Funder, JW. Adrenocorticoid-dependent alpha-lactalbumin synthesis in rat mammary gland explants-Antagonist studies. Clin Exp Pharmacol Physiol 1986; 13(3):233-239.
228. Quirk SJ, Gannell JE, Fullerton MJ, Funder JW. Specificity and mechanism of biphasic action of glucocorticoids on alpha-lactalbumin production by rat mammary gland explants. Endocrinology 1986; 118(3):909-914.
229. Jarv J, Rinken A. Muscarinic acetylcholine receptors. In: Hucho, F (ed.). Neurotransmitter Receptors. New York: Elsevier, 1993; pp. 214-217.
230. Jarv J, Toomela T, Karelson E. Dual effect of carbachol on muscarinic receptor. Biochem Mol Biol Intern 1993; 30:649-654.
231. Jarv J, Hedlund B, Bartfai T. Kinetic-studies on muscarinic antagonist-agonist competition. J Biol Chem 1980; 225(7):2649-2651.
232. Leuchenko A, Bruck J, Sternberg PW. Regulatory modules that generate biphasic signal response in biological systems. System Biol 2004; 1:139-148.
233. Quirk SJ, Funder JW. Steroid receptors, and the generation of closely coupled/biphasic dose response curves. J Steriod Biochem 1988; 30:9-15.
234. Goldstein BD, Henifin MS. Reference guide on toxicology. In: Reference Manual on Scientific Evidence, 2nd edn. Federal Judicial Center 2000; pp. P401-P438.
235. Rhomberg LR, Goodman JE, Haber LT et al. Linear low-dose extrapolation for noncancer health effects is the exception, not the rule. Crit Rev Toxicol 2011; 41(1):1-19.
236. Enstrom JE. Fine particulate air pollution and total mortality among elderly Californians, 1973-2002. Inhalation Toxicol 2005; 17(14):803-816.
237. Glende EA. Carbon tetrachloride-induced protection against carbon-tetrachloride toxicity-Role of liver microsomal drug-metabolizing system. Biochem Pharmacol 1972; 21(12):1697-1702.
238. Mehendale HM. Tissue repair: An important determinant of final outcome of toxicant-induced injury. Toxicol Pathol 2005; 33(1):41-51.
239. Mehendale HM. Once initiated, how does toxic tissue injury expand? Trends Pharmacol Sci 2012; 33(4):200-206.
240. Yoshikawa H. Preventive effect of pretreatment with low dose of metals on the acute toxicity of metals in mice. Ind Health 1970; 8:184-191.
241. Calabrese EJ, Bachmann KA, Bailer AJ et al. Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Toxicol Appl Pharmacol 2007; 222:122-128.
242. Calabrese EJ. Age and Susceptibility to Toxic Substances. New York: John Wiley and Sons, 1986; 312pp.
243. Calabrese EJ. Pollutants and High Risk Groups. New York: John Wiley and Sons, 1978; 283pp.
244. Calabrese EJ. Historical blunders: How toxicology got the dose-response relationship half right. Cell Mol Biol 2005; 51:643-654.
245. Rödel F, Frey B, Gaipl U et al. Modulation of inflammatory immune reactions by low-dose ionizing radiation: Molecular mechanisms and clinical application. Curr Med Chem 2012; 19:1741-1750.
246. Trott KR. Therapeutic effects of low radiation doses. Strahlenther Onkol 1994; 170:1-12.
247. Trott KR, Kamprad F. Estimation of cancer risks from radiotherapy of benign diseases. Strahlenther Onkol 2006; 182:431-436.
248. Arenas M, Gil F, Gironella M et al. Anti-inflammatory effects of low-dose radiotherapy in an experimental model of systemic inflammation in mice. Int J Radiat Oncol Biol Phys 2006; 66:560-567.
249. Arenas M, Gil F, Gironella M et al. Time course of anti-inflammatory effect of low-dose radiotherapy: Correlation with TGF-β1 expression. Radiother Oncol 2008; 86:399-406.
250. Weng L, Williams RU, Vieira PL et al. The therapeutic activity of low-dose irradiation on experimental arthritis depends on the induction of endogenous regulatory T cell activity. Ann Rheum Dis 2010; 69:1519-1526.
251. Hildebrandt G, Radlingmayr A, Rosenthal S et al. Low-dose radiotherapy (LD-RT) and the modulation of iNOS expression in adjuvant-induced arthritis in rats. Int J Radiat Biol 2003; 79:993-1001.
252. Hildebrandt G, Seed MP, Freemantle CN et al. Effects of low dose ionizing radiation on murine chronic granulomatous tissue. Strahlenther Onkol 1998; 174:580-588.
253. Hildebrandt G, Seed MP, Freemantle CN et al. Mechanisms of the anti-inflammatory activity of low-dose radiation therapy. Int J Radiat Biol 1998; 74:367-378.
254. Nakatsukasa H, Tsukimoto M, Ohshima Y et al. Suppressing effect of low-dose gamma-ray irradiation on collagen-induced arthritis. Radiat Res 2008; 49:381-389.
255. Nakatsukasa H, Tsukimoto M, Tokunaga A et al. Repeated γ irradiation attenuates collagen-induced arthritis via up-regulation of regulatory T cells but not by damaging lymphocytes directly. Radiat Res 2010; 174:313-324.
256. Schaue D, Jahns J, Hildebrandt G, Trott K-R. Radiation treatment of acute inflammation in mice. Int J Radiat Biol 2005; 81:657-667.
257. Frey B, Gaipl US, Sarter K et al. Whole body low dose irradiation improves the course of beginning polyarthritis in human TNF-transgenic mice. Autoimmunity 2009; 42:346-348.
258. Rödel F, Hantschel M, Hildebrandt G et al. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-κB) in EA.hy.926 endothelial cells after low-dose x-irradiation. Int J Radiat Biol 2004; 80:115-123.
259. Rödel F, Schaller U, Schultze-Mosgau S et al. The induction of TGF-β1 and NF-κB parallels a biphasic time course of leukocyte/endothelial cell adhesion following low-dose x-irradiation. Strahlenther Onkol 2004; 180:194-200.
260. Rödel F, Keilholz L, Herrmann M et al. Radiobiological mechanisms in inflammatory disease of low-dose radiation therapy. Int J Radiat Biol 2007; 83:357-366.
261. Rödel F, Hofmann D, Auer J et al. The anti-inflammatory effects of low-dose radiation therapy involves a diminished CCL20 chemokine expression and granulocyte/endothelial cell adhesion. Strahlenther Onkol 2008; 184:41-47.
262. Rödel F, Keilholz L, Herrmann M et al. Activator protein 1shows a biphasic induction and transcriptional activity after low dose x-irradiation in EA.hy.926 endothelial cells. Autoimmunity 2009; 42:343-345.
263. Rödel F, Frey B, Capalbo G et al. Discontinuous induction of x-linked inhibitor of apoptosis in EA.hy.926 endothelial cells in linked to NF-κB activation and mediates the anti-inflammatory properties of low-dose ionising-radiation. Radiat Oncol 2010; 97:346-351.
264. Rödel F, Kamprad F, Sauer R et al. Low-dose radiotherapy: Molecular and functional aspects. Strahlenther Onkol 2002; 178:1-9.
265. Roedel F, Kley N, Beuscher HU et al. Anti-inflammatory effect of low-dose x-irradiation and the involvement of a TGF-β1-induced down-regulation of leukocyte/endothelial cell adhesion. Int J Radiat Biol 2002; 78:711-719.
266. DiChiara MR, Kiely JM, Gimbrone MA Jr et al. Inhibition of E-selecting gene expression by transforming growth factor beta in endothelial cells involves coactivator integration of Smad and nuclear factor kappaB-mediated signals. J Exp Med 2000; 192:695-704.
267. Hooker A, Bhat M, Day TK et al. The linear no-threshold model does not hold for low-dose ionizing radiation. Radiat Res 2004; 162(4):447-452.
268. Choi VWY, Yum EHW, Konishi T et al. Triphasic low-dose response in Zebrafish embryos irradiated by microbeam protons. J Radiat Res 2012; 53:475-481.
269. Ames BN, Gold LS. Paracelsus to parascience: The environmental cancer distraction. Mutat Res Fundam Mol Mech Mutagen 2000; 447(1):3-13.
270. Calabrese EJ, Baldwin LA. Does exceeding the MTD increase or decrease the cancer incidence in rodent studies-A testable hypothesis. Drug Metab Rev 1992; 24(4):421-424.
271. Gold LS, Slone TH, Ames BN. What do animal cancer tests tell us about human cancer risk? Overview of analyses of the carcinogenic potency database. Drug Metab Rev 1998; 30(2):359-404.
272. Spencer WP, Stern C. Experiments to test the validity of the linear R-dose mutations frequency in Drosophila at low dosage. Genetics 1948; 33:43-74.
273. Druckrey H. Quantitative Grundlagen der Krebserzeugung. Klin Wochenschr 1943; 22:532-534.
274. Druckrey H, Küpfmüller K. Quantitative analyse der krebsentstehung. Z Naturforsch 1948; 3b:254-266.
275. Druckrey H. Quantitative aspects in chemical carcinogenesis. In: Truhaut R (ed.). Potential Carcinogenic Hazards from Drugs. UICC Monograph Series, Vol. 7. Berlin, Germany: Springer-Verlag, 1967; 60pp.
276. Druckrey H. Pharmacological approach to carcinogenesis. In: Weistenholme G, O’Connor M (eds.). CIBA Foundation Symposium on Carcinogenesis-Mechanisms of Actions. Boston, MA: Little, Brown and Co, 1959; pp. 110-130.
277. Suss R, Kinzel V, Scribner JD. Cancer: Experiments and Concepts. Berlin, Germany: Springer-Verlag, 1973; 50pp.
278. Yanysheva NY, Antomonov YG. Predicting the risk of tumor occurrence under the effect of small doses of carcinogens. Environ Health Perspect 1976; 13:95-99.
279. Jones HB, Grendon A. Environmental factor in the origin of cancer and estimation of the possible hazard to man. Food Cosmet Toxicol 1975; 13:251-268.
280. Enterline PE. Pitfalls in epidemiological research. J Occup Med 1976; 18(3):150-156.
281. OSHA. Rules on the identification, classification and regulation of potential occupation carcinogens. January 24, 1980. Fed Regist 1980; 45(15):5002-5296.
282. Guess HA, Hoel DG. The effect of dose on cancer latency period. J Environ Pathol Toxicol 1977; 1:279-286.
283. Albert RE, Altshuler B. Considerations relating to the formulation of limits for unavoidable population exposures to environmental carcinogens. In: Sander CL, Busch RH, Ballou JE, Mahlum DD (eds.). Radionuclide Carcinogenesis (Proceedings of the Twelfth Annual Hanford Biology Symposium, Richland, WA), AEC Symposium Series No. 29, Conference 720505. NTIS: Springfield, VA, 1973; pp. 233-253.
284. Albert RE, Altshuler B. Assessment of environmental carcinogen risks in terms of life shortening. Environ Health Perspect 1976; 13:91-94.
285. National Academy of Sciences (NAS). Principles for Evaluating Chemicals in the Environment. Washington, DC: National Academy of Sciences, 1975.
286. Calabrese EJ. Methodological Approaches to Deriving Environmental and Occupational Health Standards. New York: John Wiley and Sons, 1978; 402pp.
287. Uphoff DE, Stern C. The genetic effects of low intensity in irradiation. Science 1949; 109:609-610.
288. Brues AM. Critique of mutational theories of carcinogenesis. Acta Unio Internationalis Contra 1960; 16(2):415-417.
289. Brues AM. Radiation thresholds. Arch Environ Health 1971; 22:690-691.
290. Brues AM, Sacher GA. The significance of time-dose relationships in carcinogenesis. Cancer Res 1951; 11(4):240.
291. Drake JW, Abrahamson S, Crow JF et al. Environmental mutagenic hazards. Science 1975; 187:503-514.
292. Drake JW. 1978. Some guidelines for determining maximum permissible levels of chemical mutagens. In: Flamm WG, Mehlman MA (eds.). Advances in Modern Toxicology, Vol. 5-Mutagenesis. New York: Hemisphere Publishing Corporation, 1978; 926pp.
293. Freese E. Thresholds in toxic, teratogenic, mutagenic, and carcinogenic effects. Environ Health Perspect 1973; 6:171-178.
294. Frayssinet C. The principle of a threshold dose in chemical carcinogenesis. Food Addit Contam 1984; 1(2):89-94.
295. Hatch TF. Thresholds: Do they exist? Arch Environ Health 1971; 22:687-689.
296. Henschle D. New approaches to a definition of threshold values for irreversible toxic effects. Arch Toxicol 1974; 32(1):63-67.
297. Mantel N, Heston WE, Gurian JM. Thresholds in linear dose-response models for carcinogenesis. J Natl Cancer Inst 1961; 27:203-215.
298. Potter VR. How is an optimum environment defined? Environ Res 1969; 2:476-487.
299. Rall DP. Thresholds? Environ Health Perspect 1978; 22:163-165.
300. Stokinger HE. Concepts of thresholds in standards setting-Analysis of concept and its application to industrial air limits (TLVS). Arch Environ Health 1972; 25(3):153-157.
301. Falk HL. Biologic evidence for the existence of thresholds in chemical carcinogenesis. Environ Health Perspect 1978; 22:167-170.
302. Upton AC. Environmental standards for ionizing radiation-Theoretical basis for dose-response curves. Environ Health Perspect 1983; 52:31-39.
303. Ziehlhuis RL. Permissible limits for occupational exposure to toxic agents-Discussion on differences in approach between U.S. and U.S.S.R. Int Arch Arbeitmed 1974; 33(1):1-13.
304. Zeise L, Wilson R, Crouch EAC. Dose-response relationships for carcinogens: A review. Environ Health Perspect 1987; 73:259-308.
305. Zito R. Low doses and thresholds in genotoxicity: From theories to experiments. J Exp Clin Cancer Res 2001; 20(3):315-325.
306. Weisburger JH, Williams GM. The distinction between genotoxic and epigenetic carcinogens and implication for cancer risk. Toxicol Sci 2000; 57:4-5.
307. Speit G, Autrup H, Crebelli R et al. Thresholds in genetic toxicology-Concluding remarks. Mutat Res 2000; 464:149-153.
308. Slob W. Thresholds in toxicology and risk assessment. Int J Toxicol 1999; 18:259-268.
309. Purchase IFH, Auton TR. Thresholds in chemical carcinogenesis. Regul Toxicol Pharmacol 1995; 22:199-205.
310. Parry JM. Reflections on the implications of thresholds of mutagenic activity for the labeling of chemicals by the European Union. Mutat Res 2000; 464:155-158.
311. Neumann H-G. Risk assessment of chemical carcinogens and thresholds. Crit Rev Toxicol 2009; 39(6):449-461.
312. Madle S, von der Hude W, Broschinski L et al. Threshold effects in genetic toxicity: Perspective of chemicals regulation in Germany. Mutat Res 2000; 464:117-121.
313. Lovell DP. Dose-response and threshold-mediated mechanisms in mutagenesis: Statistical models and study design. Mutat Res 2000; 464:87095.
314. Kondo S. Evidence that there are threshold effects in risk of radiation. J Nuclear Sci Technol 1999; 36(1):1-9.
315. Jenkins GJS, Doak SH, Johnson GE et al. Do dose response thresholds exist for genotoxic alkylating agents? Mutagenesis 2005; 20(6):389-398.
316. Jin M, Dewa Y, Kawai M et al. The threshold dose for liver tumor promoting effects of dicyclanil in ICR mice. J Toxicol Sci 2010; 35(1):69-78.
317. Johnson GE, Doak SH, Griffiths SM et al. Nonlinear dose-response of DNA-reactive genotoxins: Recommendations for data analysis. Mutat Res Genet Toxicol Environ Mutagen 2009; 678:95-100.
318. Henderson L, Albertini S, Aardema M. Thresholds in genotoxicity responses. Mutat Res 2000; 464:123-128.
319. Hengstler JG, Bogdanffy MS, Bolt HM et al. Challenging dogma: Thresholds for genotoxic carcinogens? The case of vinyl acetate. Annu Rev Pharmacol Toxicol 2003; 43:485-520.
320. Fry RJM. The questions of thresholds for carcinogenesis. Cancer Invest 1989; 7:299-300.
321. Elmore E, Lao X-Y, Ko M et al. Neoplastic transformation in vitro induced by low doses of 232 MeV protons. Int J Radiat Biol 2005; 81:291-298.
322. Elmore E, Lao X-Y, Kapadia R et al. Threshold-type dose response for induction of neoplastic transformation by 1 GeV/nucleon iron ions. Radiat Res 2009; 171:764-770.
323. Crump KS. Use of threshold and mode of action in risk assessment. Crit Rev Toxicol 2011; 41(8):637-650.
324. Pottenger LH, Carmichael N, Banton MI et al. ECETOCworkshop on the biological significance of DNA adducts: Summary of follow-up from an expert panel meeting. Mutat Res Genet Toxicol Environ Mutagen 2009; 678:152-157.
325. Steenland K, Mannetje A, Boffetta P et al. Pooled exposureresponse and risk assessment for lung cancer in 10 cohorts of silica-exposed workers: An IARC multicentre study. Cancer Causes Control 2001; 12:773-784.
326. Calabrese EJ. Hormesis: Principles and applications for pharmacology and toxicology. Am J Pharmacol Toxicol 2008; 3(1):56-68.
327. Clark DH. Alfred Joseph Clark (1885-1941). A Memoir. Glastonbury, England: C and J Clark Ltd, 1985; 61pp.
328. Sukata T, Uwagawa S, Ozaki K et al. Detailed low-dose study of 1, 1-BIS(p-chlorophenyl)-2, 2, 2-trichloroethane carcinogenesis suggests the possibility of a hormetic effect. Int J Cancer 2002; 99:112-118.